about
Nanocarriers Usage for Drug Delivery in Cancer TherapyNanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetesNanostructures for the Inhibition of Viral InfectionsNanocarriers for diagnosis and targeting of breast cancerThe potential of magneto-electric nanocarriers for drug deliveryCurrent approaches to enhance CNS delivery of drugs across the brain barriersGold nanoparticles: From nanomedicine to nanosensing.Micelles and nanoparticles for ultrasonic drug and gene delivery.Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials.Hydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization, and in vitro drug release study.Nanoparticle penetration and transport in living pumpkin plants: in situ subcellular identificationTargeted delivery of amikacin into granuloma.A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyOptimal structural design of mannosylated nanocarriers for macrophage targeting.Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Distributions.Critical evaluation of biodegradable polymers used in nanodrugs.Synthesis and bioevaluation of ¹²⁵I-labeled gold nanorods.Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer.Aptamer-labeled PLGA nanoparticles for targeting cancer cells.In Ovo Administration of Silver Nanoparticles and/or Amino Acids Influence Metabolism and Immune Gene Expression in Chicken Embryos.Impact of nanotechnology in cancer: emphasis on nanochemopreventionQuantitatively Understanding Cellular Uptake of Gold Nanoparticles via Radioactivity Analysis.Small-molecule delivery by nanoparticles for anticancer therapyThe implications of stochastic synthesis for the conjugation of functional groups to nanoparticles.Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes.From bench to bedside: the growing use of translational research in cancer medicine.Recent advances in the field of nanometric drug carriers.Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.Ceramic nanocarriers: versatile nanosystem for protein and peptide delivery.Metallic nanoparticles: microbial synthesis and unique properties for biotechnological applications, bioavailability and biotransformation.Nanomicellar carriers for targeted delivery of anticancer agents.Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.Ceramic nanoparticles: Recompense, cellular uptake and toxicity concerns.Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.Cancer immunotherapy: nanodelivery approaches for immune cell targeting and trackingIn ovo silver nanoparticle supplementation for improving the post-hatch immunity status of broiler chickens.Dendrimers for theranostic applications.Fluorescent nanoparticles for the accurate detection of drug delivery.
P2860
Q26740048-54538C27-E3D0-4982-926C-BC291DB766D7Q26779447-126B2DCF-5216-46D1-8408-7F3CD6AFC742Q26801513-BE4EC0D9-D78D-414C-AC7D-9A74BF1377FDQ26862309-95134B7F-B29B-43DC-A226-F5D8016994C4Q30403718-9AAD422C-A081-42B6-B4D7-4BFD1D1D4E08Q30437835-DE7B88B8-4B9B-45D7-9FF4-2F9B94FF94E3Q30447539-DCA77B53-7CF3-45B1-BCE9-62DAA37E514CQ30488678-6B3ABCAA-785D-441A-81AF-67A01E69D6FCQ30781853-191F227D-15FB-4F9D-AAD3-E323370687F4Q33349360-6BB5099E-157E-42ED-B585-63A8F8FAF75BQ33434185-DE1502F6-1962-4E84-856D-F24FD9321CD1Q33652356-E3A3B20F-A87C-4920-95C6-6DE169F6B4B9Q33718722-3D7C69EA-D7E6-49E8-BA05-ECCACAF294C4Q33859472-C37CD65A-B433-47C4-826C-67F16B334431Q34623115-985D566A-A25E-484A-B2D8-2CCD9E83D455Q34666766-B8182620-EC7C-4887-9F76-B11EF5793560Q34976931-D9991763-DA41-402C-A166-597302F29A9DQ35115589-330FA752-2EF4-4660-91D0-81A9100230E1Q35578037-DEEECCF6-2543-464C-B39A-09A1DA790F85Q35673856-5C2BCADE-791B-4509-9597-4BCE01D5BC26Q35722875-89CDE573-BCBD-4EED-8744-F43583E47456Q35750624-CD16239D-1EA4-4A29-B4C7-A9F4E2030D2CQ35822502-B639C0FD-1054-4ED8-BC93-252238CB54EEQ37059874-433F108E-FA9B-4059-82E1-0B80F7DEE7D5Q37119874-8101C6F6-0BA8-4C7B-B4E1-F00FD6C343C3Q37361025-7553A441-8238-4BA4-81D4-9CD57A879E01Q37370429-40D4BA5D-29D7-4CB5-93CD-A1C1FE6CE237Q37698244-55D2C822-1C95-43D8-A92E-BEAADA924D8FQ37855847-DC4E28FF-476C-4ACA-9783-E3E5DB0E7755Q38038897-60FB9AE1-A12F-4EC3-AFCB-4464F18157DFQ38069606-D4843DBF-63AB-4C56-AAF6-051D0D528A83Q38128362-72027EF9-0D55-4BFC-816B-C6C9A1FDBA56Q38171564-64558FC0-A16A-4A7C-AC14-A9E859E88781Q38199540-70A234BE-A807-40B9-8F48-5F167A4DC472Q38250374-7B87B943-A91E-466E-ACCC-1C3DF3962343Q38273695-BC008740-D4A4-4B97-92C0-19EF669051E4Q38288055-F9E861E4-668A-492E-A1C2-7549DE40F99BQ38403503-7C33E696-0ED7-4CFC-B654-B8CA28C30F67Q38542021-E2E9964B-2FFB-4693-B140-04C1F20DD04EQ38570366-EAC666D5-0217-4C54-956E-B7B386F41DC7
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Nanocarriers: promising vehicle for bioactive drugs.
@ast
Nanocarriers: promising vehicle for bioactive drugs.
@en
type
label
Nanocarriers: promising vehicle for bioactive drugs.
@ast
Nanocarriers: promising vehicle for bioactive drugs.
@en
prefLabel
Nanocarriers: promising vehicle for bioactive drugs.
@ast
Nanocarriers: promising vehicle for bioactive drugs.
@en
P2093
P356
P1476
Nanocarriers: promising vehicle for bioactive drugs.
@en
P2093
Deependra Singh
Manju Rawat
Swarnlata Saraf
P304
P356
10.1248/BPB.29.1790
P577
2006-09-01T00:00:00Z